Recent Press Releases

High-visibility Investments in M3 Biotechnology and its Drug to Reverse Alzheimer's, Parkinson's Lead Successful Funding Round

SEATTLE, Feb. 11, 2016 /PRNewswire/ -- M3 Biotechnology Inc., spurred by a major "team investment" by Bruce Montgomery, one of this area's most prominent biotech executives, and his...

Ocugen Expands Ophthalmology Portfolio

Announces License Agreement with University of Illinois at Chicago (UIC) for OCU300; Patent Allowed for OCU200, Novel, Preclinical Biologic in Development for Wet AMD MALVERN, Pa. &...

Clovis Oncology Announces Rociletinib New Drug Application Scheduled for Presentation at Upcoming FDA Oncologic Drugs Advisory Committee Meeting

BOULDER, Colo.--()--Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the U.S. Food and Drug Administration (FDA) has scheduled the New Drug Application (NDA) for rociletinib...

Unum Therapeutics Appoints Jörn Aldag, an Acclaimed Biotechnology Veteran and Gene Therapy Pioneer, to its Board of Directors

February 09, 2016 08:00 AM Eastern Standard Time CAMBRIDGE, Mass.--(BUSINESS WIRE)--Unum Therapeutics, a company developing a universal cellular immunotherapy to treat multiple cancers, today...

Astellas Names James Robinson President, Americas Operations

NORTHBROOK, Ill., Feb. 8, 2016 /PRNewswire/ -- Astellas Pharma Inc. President and Chief Executive Officer Yoshihiko Hatanaka today announced the promotion of James Robinson as president, Americas...

Eric Setzer Appointed CFO Of AVISTA Pharma

DURHAM, N.C., Feb. 8, 2016 /PRNewswire/ -- Avista Pharma Solutions ("Avista Pharma") announced today that it has appointed Eric Setzer as Chief Financial Officer (CFO). Mr. Setzer is a...

Vestagen Nabs $7 Million and a New CEO

- Funds to Support Commercialization of VESTEX® Active Barrier Healthcare Apparel Proven to Reduce Acquisition and Retention of Dangerous Contaminants - - New CEO Bill Bold Has Two Decades of...

Intarcia Appoints Dr. John Yee Into New Role Of VP, Global Medical Affairs, Safety And Operations, Reporting Directly To Chairman & CEO Kurt Graves

BOSTON, Feb. 8, 2016 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the appointment of John Yee, MD, MPH, into the newly created role of Vice President, Head of Global Medical Affairs,...

Agios (AGIO) Appoints Steve Hoerter As Chief Commercial Officer

CAMBRIDGE, Mass., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the...

Dr. Paul VanVeldhuisen Named Chief Operating Officer Of The Emmes Corporation

ROCKVILLE, Md., Feb. 8, 2016 /PRNewswire-USNewswire/ -- The Emmes Corporation today announced that Dr. Paul VanVeldhuisen has been promoted to the newly created position of chief operating officer....

Patheon Appoints Andrew G. Long as Senior Vice President and Global Business Controller

DURHAM, N.C.--(BUSINESS WIRE)--Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, has hired Andrew G. Long as...

Asuragen, Inc. Names Colin Hill Senior Vice President Of Commercial Operations

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a global molecular diagnostics company, announced today that it has appointed Colin Hill as Senior Vice President of Commercial Operations. Colin will...

Insulet (PODD) Appoints David A. Lemoine To Board Of Directors

BILLERICA, Mass., Feb. 9, 2016 /PRNewswire/ -- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management...

Implanet Announces the Appointment of Brian T. Ennis to Head Its US Subsidiary

Over 30 years of experience in the innovative medical technologies sector with global leaders and growth companies BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext:...

Avilex Appoints Mark Treherne As Its New Chief Executive Officer

The Danish biotech Avilex Pharma, developing innovtive treatments for ischaemic stroke, announces that it has appointed Dr Mark Treherne as its new Chief Executive Officer (CEO). Mark Treherne has a...

Tergus Pharma Hires Top Manufacturing Executive

SAN FRANCISCO, CA--(Marketwired - Feb 10, 2016) - In a move that will further cement Tergus Pharma's (www.terguspharma.com) position as the industry leader in topical clinical supply...

Astellas (ALPMY) Names James Robinson President, Americas Operations

NORTHBROOK, Ill., Feb. 8, 2016 /PRNewswire/ -- Astellas Pharma Inc. President and Chief Executive Officer Yoshihiko Hatanaka today announced the promotion of James Robinson as president, Americas...

Cepheid (CPHD) Announces Appointment Of President And Chief Operating Officer And Welcomes Executive Vice President Of Engineering And Operations

SUNNYVALE, Calif., Feb. 10, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that Warren Kocmond, formerly Executive Vice President and Chief Operating Officer, has been promoted to the...

Galmed Pharmaceuticals Announces Retirement Of Chief Medical Officer

TEL AVIV, Israel, Feb. 11, 2016 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of a...
'